• Oral peptide delivery is constrained by GI proteolysis and unfavourable physicochemical properties
• Unnatural amino acids enable systematic expansion of peptide design space
• A pancreatin assay quantifies susceptibility to intestinal degradation
• Integrated physicochemical data guide rational design for oral stability and bioavailability
Magdalena Kierkowicz, Senior Scientist, UCB
